Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
1
|
Towards an improved investment approach for an effective response to HIV/AIDS.
|
Lancet
|
2011
|
11.89
|
2
|
An assessment of interactions between global health initiatives and country health systems.
|
Lancet
|
2009
|
10.53
|
3
|
Expansion of cancer care and control in countries of low and middle income: a call to action.
|
Lancet
|
2010
|
6.84
|
4
|
UK investments in global infectious disease research 1997-2010: a case study.
|
Lancet Infect Dis
|
2012
|
5.42
|
5
|
Technologies for global health.
|
Lancet
|
2012
|
5.05
|
6
|
Prevention of mother-to-child transmission of HIV and the health-related Millennium Development Goals: time for a public health approach.
|
Lancet
|
2011
|
5.00
|
7
|
Equity and adequacy of international donor assistance for global malaria control: an analysis of populations at risk and external funding commitments.
|
Lancet
|
2010
|
3.73
|
8
|
Mobile phone messaging for facilitating self-management of long-term illnesses.
|
Cochrane Database Syst Rev
|
2012
|
3.70
|
9
|
Universal access to malaria medicines: innovation in financing and delivery.
|
Lancet
|
2010
|
3.31
|
10
|
Mobile phone messaging reminders for attendance at healthcare appointments.
|
Cochrane Database Syst Rev
|
2012
|
2.87
|
11
|
Is operational research delivering the goods? The journey to success in low-income countries.
|
Lancet Infect Dis
|
2012
|
2.62
|
12
|
Risk factors for pulmonary tuberculosis in Russia: case-control study.
|
BMJ
|
2005
|
2.44
|
13
|
Mobile phone messaging reminders for attendance at healthcare appointments.
|
Cochrane Database Syst Rev
|
2013
|
2.42
|
14
|
Mobile phone messaging for preventive health care.
|
Cochrane Database Syst Rev
|
2012
|
2.15
|
15
|
Economic returns to investment in AIDS treatment in low and middle income countries.
|
PLoS One
|
2011
|
1.98
|
16
|
Tuberculosis diagnostics and biomarkers: needs, challenges, recent advances, and opportunities.
|
J Infect Dis
|
2012
|
1.89
|
17
|
Funding for malaria control 2006-2010: a comprehensive global assessment.
|
Malar J
|
2012
|
1.87
|
18
|
Guidance for evidence-informed policies about health systems: rationale for and challenges of guidance development.
|
PLoS Med
|
2012
|
1.81
|
19
|
Social, economic, human rights and political challenges to global mental health.
|
Ment Health Fam Med
|
2011
|
1.72
|
20
|
Drug-resistant tuberculosis--current dilemmas, unanswered questions, challenges, and priority needs.
|
J Infect Dis
|
2012
|
1.72
|
21
|
Market failure and the poverty of new drugs in maternal health.
|
PLoS Med
|
2008
|
1.70
|
22
|
Scale-up of services and research priorities for diagnosis, management, and control of tuberculosis: a call to action.
|
Lancet
|
2010
|
1.69
|
23
|
Guidance for evidence-informed policies about health systems: linking guidance development to policy development.
|
PLoS Med
|
2012
|
1.68
|
24
|
Integrating tuberculosis and HIV services in low- and middle-income countries: a systematic review.
|
Trop Med Int Health
|
2012
|
1.66
|
25
|
Lives saved by tuberculosis control and prospects for achieving the 2015 global target for reducing tuberculosis mortality.
|
Bull World Health Organ
|
2011
|
1.64
|
26
|
Global health initiative investments and health systems strengthening: a content analysis of global fund investments.
|
Global Health
|
2013
|
1.60
|
27
|
International and national policy challenges in mental health.
|
Ment Health Fam Med
|
2011
|
1.58
|
28
|
An analysis of GAVI, the Global Fund and World Bank support for human resources for health in developing countries.
|
Health Policy Plan
|
2012
|
1.58
|
29
|
Relative and absolute addressability of global disease burden in maternal and perinatal health by investment in R&D.
|
Trop Med Int Health
|
2011
|
1.57
|
30
|
Health systems strengthening: a common classification and framework for investment analysis.
|
Health Policy Plan
|
2010
|
1.56
|
31
|
Health system challenges and solutions to improving mental health outcomes.
|
Ment Health Fam Med
|
2011
|
1.53
|
32
|
Beyond borders: public-health surveillance.
|
Lancet
|
2006
|
1.49
|
33
|
Public-private partnerships for hospitals.
|
Bull World Health Organ
|
2006
|
1.46
|
34
|
Integrating prevention of mother-to-child HIV transmission (PMTCT) programmes with other health services for preventing HIV infection and improving HIV outcomes in developing countries.
|
Cochrane Database Syst Rev
|
2011
|
1.41
|
35
|
Health systems, systems thinking and innovation.
|
Health Policy Plan
|
2012
|
1.41
|
36
|
Integrating prevention of mother-to-child HIV transmission programs to improve uptake: a systematic review.
|
PLoS One
|
2012
|
1.40
|
37
|
Tuberculosis in prisons in sub-Saharan Africa--the need for improved health services, surveillance and control.
|
Tuberculosis (Edinb)
|
2011
|
1.40
|
38
|
Rethinking health systems strengthening: key systems thinking tools and strategies for transformational change.
|
Health Policy Plan
|
2012
|
1.34
|
39
|
Systematic analysis of funding awarded for antimicrobial resistance research to institutions in the UK, 1997-2010.
|
J Antimicrob Chemother
|
2013
|
1.34
|
40
|
Effect of investment in malaria control on child mortality in sub-Saharan Africa in 2002-2008.
|
PLoS One
|
2011
|
1.32
|
41
|
Prevention of HIV/AIDS among injecting drug users in Russia: opportunities and barriers to scaling-up of harm reduction programmes.
|
Health Policy
|
2007
|
1.31
|
42
|
Health systems, communicable diseases and integration.
|
Health Policy Plan
|
2010
|
1.29
|
43
|
Mental health and the global agenda: core conceptual issues.
|
Ment Health Fam Med
|
2011
|
1.28
|
44
|
Why do health systems matter? Exploring links between health systems and HIV response: a case study from Russia.
|
Health Policy Plan
|
2010
|
1.23
|
45
|
Mobile phone messaging for communicating results of medical investigations.
|
Cochrane Database Syst Rev
|
2012
|
1.23
|
46
|
Scaling up research and learning for health systems: time to act.
|
Lancet
|
2008
|
1.22
|
47
|
Positive spill-over effects of ART scale up on wider health systems development: evidence from Ethiopia and Malawi.
|
J Int AIDS Soc
|
2011
|
1.22
|
48
|
Antimicrobial prescribing patterns for respiratory diseases including tuberculosis in Russia: a possible role in drug resistance?
|
J Antimicrob Chemother
|
2004
|
1.19
|
49
|
Differences in research funding for women scientists: a systematic comparison of UK investments in global infectious disease research during 1997-2010.
|
BMJ Open
|
2013
|
1.17
|
50
|
Long-term costs and health impact of continued global fund support for antiretroviral therapy.
|
PLoS One
|
2011
|
1.16
|
51
|
The uptake of integrated perinatal prevention of mother-to-child HIV transmission programs in low- and middle-income countries: a systematic review.
|
PLoS One
|
2013
|
1.14
|
52
|
Global Fund financing of public-private mix approaches for delivery of tuberculosis care.
|
Trop Med Int Health
|
2011
|
1.11
|
53
|
Systematic analysis of funding awarded for norovirus research to institutions in the United Kingdom, 1997-2010.
|
J R Soc Med
|
2013
|
1.10
|
54
|
Mental health reform in the Russian Federation: an integrated approach to achieve social inclusion and recovery.
|
Bull World Health Organ
|
2007
|
1.08
|
55
|
Investments in respiratory infectious disease research 1997-2010: a systematic analysis of UK funding.
|
BMJ Open
|
2014
|
1.05
|
56
|
Long-term care of AIDS and non-communicable diseases.
|
Lancet
|
2011
|
1.04
|
57
|
Viewpoint: Scientific dogmas, paradoxes and mysteries of latent Mycobacterium tuberculosis infection.
|
Trop Med Int Health
|
2011
|
1.03
|
58
|
Implementing the global plan to stop TB, 2011-2015--optimizing allocations and the Global Fund's contribution: a scenario projections study.
|
PLoS One
|
2012
|
1.01
|
59
|
Scaling up towards international targets for AIDS, tuberculosis, and malaria: contribution of global fund-supported programs in 2011-2015.
|
PLoS One
|
2011
|
1.01
|
60
|
Eliminating tuberculosis and tuberculosis-HIV co-disease in the 21st century: key perspectives, controversies, unresolved issues, and needs.
|
J Infect Dis
|
2012
|
0.99
|
61
|
Tuberculosis and tuberculosis/HIV/AIDS-associated mortality in Africa: the urgent need to expand and invest in routine and research autopsies.
|
J Infect Dis
|
2012
|
0.99
|
62
|
Infectious disease research investments follow colonial ties: questionable ethics.
|
Int Health
|
2014
|
0.97
|
63
|
HIV epidemics and prevention responses in Asia and Eastern Europe: lessons to be learned?
|
AIDS
|
2010
|
0.96
|
64
|
Research on implementation of interventions in tuberculosis control in low- and middle-income countries: a systematic review.
|
PLoS Med
|
2012
|
0.95
|
65
|
Interactions between critical health system functions and HIV/AIDS, tuberculosis and malaria programmes.
|
Health Policy Plan
|
2010
|
0.95
|
66
|
Adoption of rapid diagnostic tests for the diagnosis of malaria, a preliminary analysis of the Global Fund program data, 2005 to 2010.
|
PLoS One
|
2012
|
0.94
|
67
|
Global health priorities and research funding--authors' reply.
|
Lancet Infect Dis
|
2013
|
0.93
|
68
|
A conceptual and analytical approach to comparative analysis of country case studies: HIV and TB control programmes and health systems integration.
|
Health Policy Plan
|
2010
|
0.93
|
69
|
Investing in improved performance of national tuberculosis programs reduces the tuberculosis burden: analysis of 22 high-burden countries, 2002-2009.
|
J Infect Dis
|
2012
|
0.90
|
70
|
The Global Fund's resource allocation decisions for HIV programmes: addressing those in need.
|
J Int AIDS Soc
|
2011
|
0.90
|
71
|
Changing HIV treatment eligibility under health system constraints in sub-Saharan Africa: investment needs, population health gains, and cost-effectiveness.
|
AIDS
|
2016
|
0.90
|
72
|
Should development agencies care about mental health?
|
Ment Health Fam Med
|
2011
|
0.88
|
73
|
Public-private partnership in cord blood banking.
|
BMJ
|
2008
|
0.88
|
74
|
Innovating for impact: the Affordable Medicines Facility-malaria (AMFm).
|
Nat Med
|
2009
|
0.87
|
75
|
Indicators measuring the performance of malaria programs supported by the global fund in Asia, progress and the way forward.
|
PLoS One
|
2011
|
0.87
|
76
|
Expanding the generation and use of economic and financial data to improve HIV program planning and efficiency: a global perspective.
|
J Acquir Immune Defic Syndr
|
2011
|
0.87
|
77
|
Negative health system effects of Global Fund's investments in AIDS, tuberculosis and malaria from 2002 to 2009: systematic review.
|
JRSM Short Rep
|
2012
|
0.87
|
78
|
Know your epidemic, know your response: targeting HIV in Asia.
|
AIDS
|
2010
|
0.87
|
79
|
Sexual and reproductive health activities in HIV programmes: can we monitor progress?
|
J Epidemiol Community Health
|
2010
|
0.86
|
80
|
Unemployment, government healthcare spending, and cerebrovascular mortality, worldwide 1981-2009: an ecological study.
|
Int J Stroke
|
2015
|
0.86
|
81
|
Emergence of multilateral proto-institutions in global health and new approaches to governance: analysis using path dependency and institutional theory.
|
Global Health
|
2013
|
0.86
|
82
|
Venice Statement on global health initiatives and health systems.
|
Lancet
|
2009
|
0.85
|
83
|
SMS text message healthcare appointment reminders in England.
|
J Ambul Care Manage
|
2008
|
0.85
|
84
|
Sex, drugs and economic behaviour in Russia: a study of socio-economic characteristics of high risk populations.
|
Int J Drug Policy
|
2010
|
0.84
|
85
|
HPTN 052 and the future of HIV treatment and prevention.
|
Lancet
|
2011
|
0.83
|
86
|
Global Fund investments in harm reduction from 2002 to 2009.
|
Int J Drug Policy
|
2012
|
0.83
|
87
|
Systematic analysis of funding awarded for mycology research to institutions in the UK, 1997-2010.
|
BMJ Open
|
2014
|
0.83
|
88
|
How can mental health be integrated into health system strengthening?
|
Ment Health Fam Med
|
2011
|
0.81
|
89
|
The effects of Global Fund financing on health governance in Brazil.
|
Global Health
|
2012
|
0.81
|
90
|
Scaling up mental health services: where would the money come from?
|
Ment Health Fam Med
|
2011
|
0.80
|
91
|
Mental health care reforms in Europe: Rehabilitation and social inclusion of people with mental illness in Russia.
|
Psychiatr Serv
|
2010
|
0.80
|
92
|
Global fund financing of tuberculosis services delivery in prisons.
|
J Infect Dis
|
2012
|
0.80
|
93
|
What action can national and international agencies take?
|
Ment Health Fam Med
|
2011
|
0.79
|
94
|
Infectious disease research investments: systematic analysis of immunology and vaccine research funding in the UK.
|
Vaccine
|
2013
|
0.78
|
95
|
Seizing the opportunity to close the cancer divide.
|
Lancet
|
2013
|
0.78
|
96
|
HIV in Asia: universal access in sight.
|
AIDS
|
2010
|
0.77
|
97
|
Bridging the divide.
|
J Acquir Immune Defic Syndr
|
2011
|
0.77
|
98
|
Maternal mortality for 181 countries, 1980-2008.
|
Lancet
|
2010
|
0.77
|
99
|
Telephone consultation for improving health of people living with or at risk of HIV: a systematic review.
|
PLoS One
|
2012
|
0.75
|
100
|
Public-private partnerships in health: time for evidence-based policies.
|
Heart
|
2008
|
0.75
|
101
|
Beyond the bench and the bedside: economic and health systems dimensions of global childhood cancer outcomes.
|
Pediatr Blood Cancer
|
2013
|
0.75
|
102
|
How much will it cost? Estimation of resource needs and availability for HIV prevention, treatment and care for people who inject drugs in Asia.
|
Int J Drug Policy
|
2010
|
0.75
|
103
|
Asia can afford universal access for AIDS prevention and treatment.
|
AIDS
|
2010
|
0.75
|